FOLD Q1 2021 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$66M+9.7% YoY

Gross Profit

$60M90.2% margin

Operating Income

-$53M-79.9% margin

Net Income

-$66M-98.9% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-5.9%

Cash Flow

Operating Cash Flow

-$72M

Free Cash Flow

-$73M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$810M

Total Liabilities

$559M

Stockholders' Equity

$251M

Cash & Equivalents

$185M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$61M	+9.7%
Gross Profit	$60M	$54M	+10.9%
Operating Income	-$53M	-$78M	+32.0%
Net Income	-$66M	-$89M	+26.2%

Geographic Segments

Non-US

$46M69%

UNITED STATES

$21M31%